Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-09-02

FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for Malarone (atovaquone and proguanil hydrochloride) manufactured by GlaxoSmithKline LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)

Snippet

SUPPL AP for MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)